Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 5

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 5
---
───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  The key patents that underlie Deep TMS technology are subject to the U. S. government’s                                                  
  royalty free usage rights on a worldwide basis for any discovery based on such patents, which may have unexpected, adverse consequences  
  on the market for our product.                                                                                                           
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  If we are unable to protect the confidentiality of our trade secrets or know-how, such  
  proprietary information may be used by others to compete against us.                    
 ──────────────────────────────────────────────────────────────────────────────────────────

  Legal proceedings or third-party claims of intellectual property infringement and other                                                
  challenges, whether with or without merit, may require us to spend substantial time and money and could prevent us from developing or  
  commercializing Deep TMS.                                                                                                              
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Foreign Country Risks

  The Israeli government grants that we received require us to meet several conditions,                                                           
  may restrict our ability to manufacture our Deep TMS systems and transfer relevant know-how outside of Israel and require us to pay royalties,  
  including increased royalties if we manufacture our Deep TMS systems outside of Israel or payment of a redemption fee if we transfer relevant   
  know-how outside of Israel.                                                                                                                     
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  We have manufacturing, assembly and other significant functions that are located in                                                     
  Israel and, therefore, our business and operations may be adversely affected by political, economic and military conditions in Israel.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Exchange rate fluctuations between the U. S. dollar, the New Israeli Shekel and other  
  foreign currencies may negatively affect our future results of operations.             
 ─────────────────────────────────────────────────────────────────────────────────────────

  The price of our American Depositary Shares, or ADSs, may be volatile and may fluctuate  
  due to factors beyond our control.                                                       
 ───────────────────────────────────────────────────────────────────────────────────────────

  The significant share ownership position of several of our officers,                                                              
  directors, and entities affiliated with certain of our directors, including Valor, may limit